Berkeley Lights, Inc.

Good afternoon. My name is Stephanie, and I will be your conference operator today. At this time, I would like to welcome everyone to Berkeley Light's first quarter 2022 earnings conference call. All lines have been placed on mute to prevent any background noise. After the speaker's remarks, there will be a question and answer session. If you would like to ask a question during this time, simply press star and the number one on your telephone keypad. If you would like to withdraw your question, again, press the star one. Suzanne Hatcher, Vice President of Communications and Investor Relations.

You may begin your conference.

Thank you. Good afternoon, everyone, and welcome to Berkeley Light's first quarter 2022 earnings call reporting financial results ended March 31, 2022. My name is Suzanne Hatcher, Vice President of Communications and Investor Relations. I'm joined today by members of the Berkeley Light management team, including Dr. Siddhartha Eskadia, Chief Executive Officer, Paul McCloskey, Chief Accounting Officer, Dr. Eric Hobbs, President of Antibody Therapeutics, and Jeff Brown, Vice President of FP&A. Before we begin, I'd like to remind you that management will make statements during this call that are forward-looking statements within the meaning of federal securities laws. These statements involve material risk and uncertainties that could cause actual resource or events to materially differ from those anticipated. For more information, please refer to the risks, uncertainties, and other factors discussed in our SEC filing. Except as required by law, Berkeley likes to claim any intention or obligation to update or revise any financial projections or forward-looking statements, whether because of new information, future events, or otherwise. This conference call contains time-sensitive information and is accurate only as a live broadcast of May 9th, 2022.